FDA clears Pear's digital insomnia therapeutic through 510(k), Pre-Cert pilot pathways

Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces.


This is a companion discussion topic for the original entry at https://www.mobihealthnews.com/news/fda-clears-pears-digital-insomnia-therapeutic-through-510k-pre-cert-pilot-pathways